Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution
Brand names: Cardioplegic Solution
Category: Cardiovascular
FDA status: To Be Discontinued · Last FDA update: Aug 31, 2026 · First posted: Aug 31, 2026 · 1 manufacturers, 1 listed presentations
As of Aug 31, 2026, the FDA lists Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10) NDC 65219-258-10 |
Fresenius Kabi USA, LLC | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution (FDA data as of Aug 31, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/potassium-chloride-sodium-chloride-calcium-chloride-b45d13.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).